ProAssurance (NYSE:PRA) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of ProAssurance (NYSE:PRA - Free Report) in a research report report published on Thursday. The firm issued a hold rating on the insurance provider's stock.

Other analysts have also recently issued research reports about the stock. Raymond James cut shares of ProAssurance from a "market perform" rating to an "underperform" rating in a research note on Thursday, April 10th. Citigroup downgraded ProAssurance to a "market perform" rating in a research report on Thursday, April 3rd. Finally, Citizens Jmp lowered ProAssurance from an "outperform" rating to a "market perform" rating in a research note on Thursday, April 3rd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat.com, ProAssurance presently has an average rating of "Hold" and an average price target of $18.67.

ProAssurance Stock Performance

Shares of PRA stock traded up $0.14 during mid-day trading on Thursday, reaching $23.02. The stock had a trading volume of 602,556 shares, compared to its average volume of 417,068. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.35. ProAssurance has a 1-year low of $10.76 and a 1-year high of $23.70. The firm has a market cap of $1.18 billion, a price-to-earnings ratio of 27.73 and a beta of -0.09. The business's fifty day moving average is $19.37 and its 200-day moving average is $16.95.

ProAssurance (NYSE:PRA - Get Free Report) last released its earnings results on Monday, February 24th. The insurance provider reported $0.36 EPS for the quarter, topping analysts' consensus estimates of $0.17 by $0.19. ProAssurance had a net margin of 3.71% and a return on equity of 2.65%. The business had revenue of $287.52 million during the quarter, compared to analysts' expectations of $274.56 million. On average, research analysts forecast that ProAssurance will post 0.8 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of PRA. Sterling Capital Management LLC increased its stake in ProAssurance by 859.4% during the fourth quarter. Sterling Capital Management LLC now owns 1,631 shares of the insurance provider's stock worth $26,000 after purchasing an additional 1,461 shares during the period. GAMMA Investing LLC increased its position in shares of ProAssurance by 307.3% during the first quarter. GAMMA Investing LLC now owns 2,073 shares of the insurance provider's stock worth $48,000 after acquiring an additional 1,564 shares during the period. KBC Group NV raised its stake in shares of ProAssurance by 75.4% in the fourth quarter. KBC Group NV now owns 4,184 shares of the insurance provider's stock valued at $67,000 after acquiring an additional 1,798 shares in the last quarter. Aquatic Capital Management LLC boosted its holdings in ProAssurance by 148.6% in the fourth quarter. Aquatic Capital Management LLC now owns 6,214 shares of the insurance provider's stock valued at $99,000 after purchasing an additional 3,714 shares during the period. Finally, First Citizens Bank & Trust Co. acquired a new position in ProAssurance during the 1st quarter worth $205,000. 85.58% of the stock is currently owned by hedge funds and other institutional investors.

ProAssurance Company Profile

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.